ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (VRX)

0,00
0,00
(0,00%)
Fermé 10 Février 10:00PM
0,00
0,00
(0,00%)
Après les heures de négociation: -

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
-
Prix Achat
-
Prix Vente
-
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Clôture Veille
-
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

VRX Dernières nouvelles

Valeant Pharmaceuticals to Announce 2009 Fourth Quarter and Year Results on February 22, 2010

ALISO VIEJO, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that it will host a conference call and a live Internet webcast along with...

FDA Accepts NDA Filing for Retigabine

MAA successfully validated by EMEA ALISO VIEJO, Calif., Dec. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that the U.S. Food and Drug...

Critical Alerts for AIG, Baidu.com, PPG, Jefferies Group, and Valeant Pharmaceuticals Released by Seven Summits Research

CHICAGO, Nov. 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AIG, BIDU, PPG, JEF, and VRX. Seven Summits Strategic Investments' PriceWatch Alerts are available at...

Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of

ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE:VRX) today announced that results from the week-72 analysis for its Phase IIb dose-finding clinical trial for...

Valeant Pharmaceuticals Reports Third Quarter Financial Results

- Revenue up 31%, 45% at constant exchange rates - GAAP EPS $0.45, Cash EPS $0.58 - GAAP Cash Flow from Operations $52 million; Adjusted Cash Flow from Operations $65 million - Increased guidance...

Valeant to Acquire Major Australian Skincare Brands

-- Dr. LeWinn's is the highest selling skincare brand in Australian pharmacies -- Hissyfit and Revitanail/Renunail brands also included in acquisition ALISO VIEJO, Calif., Sept. 30...

Valeant Provides Update on Retigabine

-- U.S. submission expected on or before October 23, 2009 -- EMEA submission expected on October 30, 2009 -- Modified Release Phase I clinical study commencing in September ALISO VIEJO, Calif...

Valeant Pharmaceuticals to Present at the UBS Global Life Sciences Conference

ALISO VIEJO, Calif., Sept. 17 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE:VRX) today announced that J. Michael Pearson, the Company's chairman and chief executive...

MultiVu Video Feed: LONNIE ALI CHAMPIONS "FIGHT FOR MORE" CAMPAIGN

Wife of Muhammad Ali Joins New Educational Campaign Supporting Parkinson's Disease Patients and Their Caregivers In the United States, 1.5 million Americans currently have Parkinson's disease...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

VRX - Frequently Asked Questions (FAQ)

What is the current share price?
The current share price of is US$ 0,00
What is the 1 year trading range for share price?
has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
LIAEStone Ridge 2050 Inflation-Protected Longevity Income ETF
US$ 173,096
(900,00%)
2
LFAIStone Ridge 2050 Longevity Income ETF
US$ 132,05
(900,00%)
3
LFAEStone Ridge 2048 Longevity Income ETF
US$ 121,596
(900,00%)
21
LIACStone Ridge 2049 Inflation-Protected Longevity Income ETF
US$ 164,999
(900,00%)
10
LFAFStone Ridge 2049 Longevity Income ETF
US$ 126,796
(900,00%)
7
CHROChannel Therapeutics Corporation
US$ 1,28
(-18,99%)
139,81k
AZTRAzitra Inc
US$ 0,3418
(-11,52%)
2,91M
CLDICalidi Biotherapeutics Inc
US$ 1,3099
(-11,49%)
2,38M
MPUMega Matrix Inc
US$ 0,8549
(-11,01%)
206,73k
SCPXScorpius Holdings Inc
US$ 0,2198
(-10,50%)
699,03k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 26,33
(-4,91%)
82,65M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 5,8796
(2,97%)
73,62M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 2,85
(7,14%)
63,71M
FXIiShares China Large Cap
US$ 32,735
(1,41%)
62,88M
ETHU2x Ether ETF
US$ 4,083
(-10,26%)
52,49M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock